NYSE: MPW

Medical Properties Trust Inc Stock Forecast, Predictions & Price Target

The consensus among 8 Wall Street analysts covering (NYSE: MPW) stock is to Hold MPW stock.

Out of 8 analysts, 0 (0%) are recommending MPW as a Strong Buy, 2 (25%) are recommending MPW as a Buy, 5 (62.5%) are recommending MPW as a Hold, 0 (0%) are recommending MPW as a Sell, and 1 (12.5%) are recommending MPW as a Strong Sell.

If you're new to stock investing, here's how to buy Medical Properties Trust stock.

(NYSE: MPW) Medical Properties Trust's forecast annual revenue growth rate of 9.81% is forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 6.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

Medical Properties Trust's revenue in 2024 is $871,799,000.On average, 5 Wall Street analysts forecast MPW's revenue for 2024 to be $705,373,150,800, with the lowest MPW revenue forecast at $607,415,508,000, and the highest MPW revenue forecast at $762,025,245,000. On average, 5 Wall Street analysts forecast MPW's revenue for 2025 to be $714,615,466,500, with the lowest MPW revenue forecast at $617,376,144,600, and the highest MPW revenue forecast at $764,900,925,000.

In 2026, MPW is forecast to generate $680,815,442,700 in revenue, with the lowest revenue forecast at $619,583,828,100 and the highest revenue forecast at $743,782,650,000.

According to 8 Wall Street analysts that have issued a 1 year MPW price target, the average MPW price target is $5.25, with the highest MPW stock price forecast at $7.00 and the lowest MPW stock price forecast at $4.50.

On average, Wall Street analysts predict that Medical Properties Trust's share price could reach $5.25 by Apr 17, 2025. The average Medical Properties Trust stock price prediction forecasts a potential upside of 18.78% from the current MPW share price of $4.42.

(NYSE: MPW) forecast ROE is N/A, which is considered weak.